Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure
- PMID: 25980356
- DOI: 10.1016/j.cmi.2015.05.005
Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure
Abstract
The clinical characteristics of patients with colistin-resistant Acinetobacter baumannii bacteraemia have been documented, but those of patients with bacteraemia caused by other Acinetobacter species remain unknown. Previous exposure to colistin has been shown to be associated with the emergence of colistin resistance, but may be not the only predisposing factor. In the current study, we highlight the risk and outcome of patients without previous exposure to colistin who acquired colistin-resistant Acinetobacter nosocomialis (ColRAN) bacteraemia. This 11-year single-centre retrospective study analysed 58 patients with ColRAN bacteraemia and 213 patients with colistin-susceptible A. nosocomialis (ColSAN) bacteraemia. Antimicrobial susceptibilities were determined with an agar dilution method. The clonal relationship of ColRAN isolates was determined with pulsed-field gel electrophoresis. A conjugation mating-out assay was conducted to delineate the potential transfer of colistin resistance genes. Multivariable analysis was performed to evaluate the risk factors for ColRAN bacteraemia. Chronic obstructive pulmonary disease (COPD) was independently associated with ColRAN bacteraemia (OR 3.04; 95% CI 1.45-6.37; p 0.003). Patients with ColRAN bacteraemia had higher APACHE II scores, but the two groups showed no significant differences in 14-day mortality (10.3% vs. 10.3%) or 28-day mortality (15.5% vs. 15.0%). ColRAN isolates had greater resistance than ColSAN isolates to all antimicrobial agents except for ciprofloxacin (0% vs. 6.6%). There were 16 different ColRAN pulsotypes, and two major clones were found. Colistin resistance did not transfer to colistin-susceptible A. baumannii or A. nosocomialis. These results show that COPD is an independent risk factor for acquisition of ColRAN bacteraemia. The mortality rates were similar between patients with ColRAN and ColSAN bacteraemia.
Keywords: Acinetobacter nosocomialis; chronic obstructive pulmonary disease; colistin resistant; mechanical ventilation; mortality.
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Multicentre study of risk factors for mortality in patients with Acinetobacter bacteraemia receiving colistin treatment.Int J Antimicrob Agents. 2020 Jun;55(6):105956. doi: 10.1016/j.ijantimicag.2020.105956. Epub 2020 Apr 9. Int J Antimicrob Agents. 2020. PMID: 32278810
-
Risk factors and clinical outcome of sulbactam nonsusceptibility in monomicrobial Acinetobacter nosocomialis bacteremia.J Microbiol Immunol Infect. 2016 Jun;49(3):371-7. doi: 10.1016/j.jmii.2014.06.004. Epub 2014 Jul 28. J Microbiol Immunol Infect. 2016. PMID: 25081987
-
Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia.Clin Microbiol Infect. 2013 Jul;19(7):634-9. doi: 10.1111/j.1469-0691.2012.03967.x. Epub 2012 Jul 10. Clin Microbiol Infect. 2013. PMID: 22776466
-
Colistin heteroresistance in Acinetobacter spp.: systematic review and meta-analysis of the prevalence and discussion of the mechanisms and potential therapeutic implications.Int J Antimicrob Agents. 2020 Aug;56(2):106065. doi: 10.1016/j.ijantimicag.2020.106065. Epub 2020 Jun 27. Int J Antimicrob Agents. 2020. PMID: 32599229
-
Treatment of Acinetobacter spp infections.Expert Opin Pharmacother. 2003 Aug;4(8):1289-96. doi: 10.1517/14656566.4.8.1289. Expert Opin Pharmacother. 2003. PMID: 12877637 Review.
Cited by
-
Diversity of metallo-β-lactamase-encoding genes found in distinct species of Acinetobacter isolated from the Brazilian Amazon Region.Mem Inst Oswaldo Cruz. 2019;114:e190020. doi: 10.1590/0074-02760190020. Epub 2019 May 30. Mem Inst Oswaldo Cruz. 2019. PMID: 31166421 Free PMC article.
-
The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii.Sci Rep. 2022 Dec 5;12(1):20951. doi: 10.1038/s41598-022-25226-x. Sci Rep. 2022. PMID: 36470921 Free PMC article.
-
Risk Factors and Prognosis of Polymyxin- and Carbapenem-Resistant Enterobacteriaceae Infections: A Propensity-Matched Real-World Study.Microorganisms. 2025 May 29;13(6):1256. doi: 10.3390/microorganisms13061256. Microorganisms. 2025. PMID: 40572145 Free PMC article.
-
Emergent Polymyxin Resistance: End of an Era?Open Forum Infect Dis. 2019 Oct 1;6(10):ofz368. doi: 10.1093/ofid/ofz368. Open Forum Infect Dis. 2019. PMID: 31420655 Free PMC article.
-
Outbreak of colistin-resistant organisms at a tertiary hospital in Riyadh, Saudi Arabia, 2016.Pan Afr Med J. 2019 Nov 26;34:162. doi: 10.11604/pamj.2019.34.162.19998. eCollection 2019. Pan Afr Med J. 2019. PMID: 32153702 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical